Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Redondo

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Science (New York, N.Y.)|June 20, 2020
Pandemics' historical role in creating inequalityLiliana M Dávalos, Rita M Austin, Mairin A Balisi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 24, 2020
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experienceL Gutierrez-Sainz, V Martinez-Marin, D Viñal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
The Anthropocene Review|May 22, 2023
The Searsville Lake Site (California, USA) as a candidate Global boundary Stratotype Section and Point for the Anthropocene seriesM Allison Stegner, Elizabeth A Hadly, Anthony D Barnosky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2016
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)A González, A Lluch, E Aba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)J Martin-Broto, A Redondo, C Valverde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2023
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trialE Pujade-Lauraine, F Selle, G Scambia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventionsA Karam, J A Ledermann, J-W Kim, et al.
Molecular Biology and Evolution|February 16, 2021
Recent Evolutionary History of Tigers Highlights Contrasting Roles of Genetic Drift and SelectionEllie E Armstrong, Anubhab Khan, Ryan W Taylor, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Science (New York, N.Y.)|June 20, 2020
Pandemics' historical role in creating inequalityLiliana M Dávalos, Rita M Austin, Mairin A Balisi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 24, 2020
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experienceL Gutierrez-Sainz, V Martinez-Marin, D Viñal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
The Anthropocene Review|May 22, 2023
The Searsville Lake Site (California, USA) as a candidate Global boundary Stratotype Section and Point for the Anthropocene seriesM Allison Stegner, Elizabeth A Hadly, Anthony D Barnosky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2016
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)A González, A Lluch, E Aba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)J Martin-Broto, A Redondo, C Valverde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2023
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trialE Pujade-Lauraine, F Selle, G Scambia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventionsA Karam, J A Ledermann, J-W Kim, et al.
Molecular Biology and Evolution|February 16, 2021
Recent Evolutionary History of Tigers Highlights Contrasting Roles of Genetic Drift and SelectionEllie E Armstrong, Anubhab Khan, Ryan W Taylor, et al.
Pageof 20